Literature DB >> 11162109

Stability engineering of antibody single-chain Fv fragments.

A Wörn1, A Plückthun.   

Abstract

The application of single-chain Fv fragments (scFv) in medicine and biotechnology places great demands on their stability. Only recently has attention been given to the production of highly stable scFvs, and in a number of examples it was found that such fragments indeed perform better during practical applications. The structural parameters influencing scFv stability are now beginning to be elucidated. This review summarizes progress in rational and evolutionary engineering methods, the structural implications of these results, as well as some examples where stability engineering has been successfully applied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162109     DOI: 10.1006/jmbi.2000.4265

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  157 in total

1.  Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.

Authors:  Ali Khoshnan; Jan Ko; Paul H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

2.  Functional aspects of co-variant surface charges in an antibody fragment.

Authors:  Nicolas Hugo; Virginie Lafont; Mervyn Beukes; Danièle Altschuh
Journal:  Protein Sci       Date:  2002-11       Impact factor: 6.725

3.  STED nanoscopy in living cells using Fluorogen Activating Proteins.

Authors:  James A J Fitzpatrick; Qi Yan; Jochen J Sieber; Marcus Dyba; Ulf Schwarz; Chris Szent-Gyorgyi; Carol A Woolford; Peter B Berget; Alan S Waggoner; Marcel P Bruchez
Journal:  Bioconjug Chem       Date:  2009       Impact factor: 4.774

4.  Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activity.

Authors:  Jianying Dong; Arlene Sereno; William B Snyder; Brian R Miller; Susan Tamraz; Adam Doern; Michael Favis; Xiufeng Wu; Hon Tran; Emma Langley; Ingrid Joseph; Antonio Boccia; Rebecca Kelly; Kathleen Wortham; Qin Wang; Lisa Berquist; Flora Huang; Sharon X Gao; Ying Zhang; Alexey Lugovskoy; Shelly Martin; Heather Gouvis; Steven Berkowitz; Gisela Chiang; Mitchell Reff; Scott M Glaser; Kandasamy Hariharan; Stephen J Demarest
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

5.  Functional mapping of the anti-idiotypic antibody anti-TS1 scFv using site-directed mutagenesis and kinetic analysis.

Authors:  Ann Erlandsson; Patrik Holm; Rozbeh Jafari; Torgny Stigbrand; Birgitta E Sundström
Journal:  MAbs       Date:  2010 Nov-Dec       Impact factor: 5.857

6.  Identification and engineering of human variable regions that allow expression of stable single-chain T cell receptors.

Authors:  David H Aggen; Adam S Chervin; Francis K Insaidoo; Kurt H Piepenbrink; Brian M Baker; David M Kranz
Journal:  Protein Eng Des Sel       Date:  2010-12-14       Impact factor: 1.650

7.  Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors:  Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2012-06-06       Impact factor: 15.419

8.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

9.  An improved single-chain Fab platform for efficient display and recombinant expression.

Authors:  James T Koerber; Michael J Hornsby; James A Wells
Journal:  J Mol Biol       Date:  2014-12-03       Impact factor: 5.469

10.  Comprehensive optimization of a single-chain variable domain antibody fragment as a targeting ligand for a cytotoxic nanoparticle.

Authors:  Kathy Zhang; Melissa L Geddie; Neeraj Kohli; Tad Kornaga; Dmitri B Kirpotin; Yang Jiao; Rachel Rennard; Daryl C Drummond; Ulrik B Nielsen; Lihui Xu; Alexey A Lugovskoy
Journal:  MAbs       Date:  2015       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.